Q4 2024 EPS Estimates for Cardinal Health, Inc. Cut by Analyst (NYSE:CAH)

Cardinal Health, Inc. (NYSE:CAH) – Equities researchers at Zacks Research lowered their Q4 2024 EPS estimates for Cardinal Health in a research note issued to investors on Wednesday, May 22nd. Zacks Research analyst D. Dey now expects that the company will earn $1.71 per share for the quarter, down from their previous estimate of $1.74. The consensus estimate for Cardinal Health’s current full-year earnings is $7.35 per share. Zacks Research also issued estimates for Cardinal Health’s Q1 2025 earnings at $1.74 EPS, Q2 2025 earnings at $1.79 EPS, Q4 2025 earnings at $2.07 EPS, FY2025 earnings at $7.55 EPS, Q1 2026 earnings at $1.68 EPS, Q2 2026 earnings at $1.78 EPS, Q3 2026 earnings at $2.15 EPS and FY2026 earnings at $7.81 EPS.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, May 2nd. The company reported $2.08 EPS for the quarter, topping analysts’ consensus estimates of $1.95 by $0.13. Cardinal Health had a negative return on equity of 54.74% and a net margin of 0.25%. The firm had revenue of $54.90 billion for the quarter, compared to the consensus estimate of $56.05 billion. During the same quarter in the prior year, the business earned $1.74 earnings per share. The company’s revenue was up 8.7% compared to the same quarter last year.

A number of other research analysts have also recently weighed in on CAH. Wells Fargo & Company cut their price objective on shares of Cardinal Health from $96.00 to $94.00 and set an “underweight” rating for the company in a report on Monday, April 29th. Leerink Partnrs reaffirmed an “outperform” rating on shares of Cardinal Health in a report on Monday, February 26th. Evercore ISI raised their price objective on Cardinal Health from $110.00 to $115.00 and gave the company an “in-line” rating in a report on Friday, May 3rd. Robert W. Baird reduced their target price on Cardinal Health from $134.00 to $128.00 and set an “outperform” rating for the company in a research note on Friday, May 3rd. Finally, UBS Group increased their target price on Cardinal Health from $122.00 to $125.00 and gave the company a “buy” rating in a research report on Monday, February 5th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $107.57.

Cardinal Health Price Performance

NYSE:CAH opened at $96.39 on Friday. The company has a 50 day moving average price of $104.75 and a 200-day moving average price of $105.45. Cardinal Health has a 1-year low of $80.90 and a 1-year high of $116.04. The firm has a market cap of $23.48 billion, a price-to-earnings ratio of 42.84, a price-to-earnings-growth ratio of 1.09 and a beta of 0.71.

Hedge Funds Weigh In On Cardinal Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Clearstead Trust LLC acquired a new stake in shares of Cardinal Health during the 4th quarter worth approximately $25,000. Raleigh Capital Management Inc. grew its position in Cardinal Health by 4,466.7% in the fourth quarter. Raleigh Capital Management Inc. now owns 274 shares of the company’s stock worth $28,000 after acquiring an additional 268 shares during the period. YHB Investment Advisors Inc. acquired a new stake in Cardinal Health during the first quarter worth $32,000. LRI Investments LLC purchased a new stake in Cardinal Health in the first quarter valued at $32,000. Finally, Cornerstone Planning Group LLC acquired a new position in shares of Cardinal Health in the 3rd quarter valued at $26,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Monday, July 1st will be paid a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a yield of 2.10%. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Monday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is 88.89%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.